Susan Kaufman

Title: Susan Kaufman: Innovator in Cancer Treatment

Introduction

Susan Kaufman is a prominent inventor based in South San Francisco, CA. She has made significant contributions to the field of cancer treatment through her innovative research and development of pharmaceutical compounds. Her work focuses on creating effective inhibitors for specific proteins involved in cancer progression.

Latest Patents

Susan Kaufman holds a patent for "Tert-butyl (s)-2-(4-(phenyl)-6H-thieno[3, 2-f][1, 2, 4]triazolo[4, 3-a][1,4]diazepin-6-yl) acetate derivatives and related compounds as bromodomain BRD4 inhibitors for treating cancer." This patent describes compounds and salts that are useful for inhibiting target polypeptides and proteins, particularly bromodomain proteins such as BRD4. The disclosure also includes pharmaceutical compositions comprising these compounds and methods for using them in the treatment of various bromodomain-mediated diseases or disorders.

Career Highlights

Throughout her career, Susan has worked with leading companies in the pharmaceutical industry, including Genentech, Inc. and F. Hoffmann-La Roche AG. Her experience in these organizations has allowed her to develop her expertise in drug discovery and development, particularly in the area of cancer therapeutics.

Collaborations

Susan has collaborated with notable professionals in her field, including Robert Anthony Blake and Peter Scott Dragovich. These collaborations have contributed to her success and the advancement of her research.

Conclusion

Susan Kaufman is a dedicated inventor whose work in cancer treatment has the potential to make a significant impact on patient care. Her innovative approach to developing bromodomain inhibitors showcases her commitment to advancing medical science.